Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + isopropyl alcohol + lidocaine hydrochloride + bupivacaine hydrochloride is a multi-component anesthetic and antiseptic kit formulation, exemplified by products like the **DYURAL 40 KIT**. This combination product is designed for the production of local or regional anesthesia while providing broad-spectrum skin antisepsis. The anesthetic components, **lidocaine hydrochloride** and **bupivacaine hydrochloride**, are amide-type local anesthetics that work by blocking voltage-gated sodium channels, thereby inhibiting nerve impulse initiation and conduction. The antiseptic components, **povidone-iodine** and **isopropyl alcohol**, are used for pre-operative skin preparation to reduce the risk of procedural site infection. These kits are typically marketed by companies such as **Asclemed USA** (Enovachem) and are often categorized as unapproved drugs by the FDA, meaning their specific combination labeling has not undergone formal FDA approval for safety and efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + isopropyl alcohol + lidocaine hydrochloride + bupivacaine hydrochloride.